Navigation Links
Global Markets for Animal Therapeutics and Diagnostics
Date:8/28/2012

NEW YORK, Aug. 28, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Markets for Animal Therapeutics and Diagnostics

http://www.reportlinker.com/p0919330/Global-Markets-for-Animal-Therapeutics-and-Diagnostics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Veterinary_healthcare

REPORT SCOPE

INTRODUCTION STUDY GOALS AND OBJECTIVES

This BCC Research report, Global Markets for Animal Therapeutics and Diagnostics, provides an overview of products included in this market and detailed market analyses and competitive environments. The study includes information about significant products, players, issues and trends, and other information affecting the animal therapeutic and diagnostic market.

REASONS FOR DOING THE STUDY

The animal health industry is responsible for maintaining the health and productivity of the over 3.3 billion livestock and 16 billion poultry worldwide and ensuring the wholesomeness and abundance of the food they produce. In addition, the industry must also cater to the health and well being of companion animals. Despite this, the human healthcare market is 35 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates and being the first to market. Despite all these risks, the industry continues to grow.

In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by large numbers of products with small revenues. Although there are hundreds of products involved in this market, only about 30 products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the arthritis and pain segments of the market.

A challenging aspect of the market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment.

INTENDED AUDIENCE

The information within this report is directed at the business and industry professional and is specifically designed to aid in the explanation, direction and future of animal health markets. The report focuses on providing the reader with an understanding of trends in the industry, market segments, market forecasts, leading players, market drivers and inhibitors.

SCOPE OF REPORT

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutic and diagnostic market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics includes products that are used at the point of care and are considered rapid tests or kits. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.

INFORMATION SOURCES

The information for this BCC report was obtained through primary and secondary data-collection methods. Primary methods included interviews with approximately 40 key executives, product managers and clinical specialists involved in the animal health industry. Secondary methods included published literature in the area of animal science and veterinary services, investment reports, company literature, and various animal health journals.

All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year of the report is 2011, with historical data provided for 2008 through 2010, and forecast data provided for 2012 and 2016. Historical, base year and forecast data are provided for each market segment of the report. Competitor market share estimates are provided for each market segment for the 2011 base year.

Although this study provides information on a variety of products used to treat animals, it does not include a comprehensive list of all products available.

ANALYST CREDENTIALS

Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals, medical devices, and emerging healthcare technologies. Ms. Elder has nearly 20 years of experience in the healthcare industry, specializing in market research for the past 14 years. This experience has given her substantial insight into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

TABLE OF CONTENTS

CHAPTER ONE: INTRODUCTION 1

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THE STUDY 1

INTENDED AUDIENCE 2

SCOPE OF REPORT 2

INFORMATION SOURCES 2

RELATED BCC RESEARCH REPORTS 3

ANALYST CREDENTIALS 3

BCC ON-LINE SERVICES 3

DISCLAIMER 3

CHAPTER TWO: SUMMARY 4

SUMMARY 4

SUMMARY TABLE TOTAL ANIMAL THERAPEUTICS AND

DIAGNOSTICS MARKET BY MAJOR SEGMENT, THROUGH 2016 ($

MILLIONS) 5

SUMMARY FIGURE TOTAL ANIMAL THERAPEUTICS AND

DIAGNOSTICS MARKET BY MAJOR SEGMENT, 2008-2016 ($

MILLIONS) 5

LEADING PRODUCTS AND MANUFACTURERS 6

CHAPTER THREE: INDUSTRY OVERVIEW 7

ANIMAL ANATOMY AND PHYSIOLOGY 7

ANIMAL ANATOMY AND PHYSIOLOGY (CONTINUED) 8

REPRODUCTIVE SYSTEM 9

TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES 10

AVIAN ANATOMY 10

Avian Anatomy (Continued) 11

Avian Anatomy (Continued) 12

TABLE 2 LIFESPAN OF COMMON PET AVIAN SPECIES 13

ANIMAL POPULATIONS IN THE UNITED STATES 13

COMPANION ANIMALS 13

TABLE 3 U S HOUSEHOLD STATISTICS FOR COMPANION

ANIMALS, 2011 (THOUSANDS) 14

TABLE 4 U S ESTIMATED POPULATIONS OF COMPANION

ANIMALS, 2011 (THOUSANDS) 14

FOOD PRODUCTION ANIMALS 14

TABLE 5 U S REPORTED POPULATION OF FOOD PRODUCTION

ANIMALS, 2005 AND 2010* (MILLIONS) 15

ANIMAL POPULATIONS BY COUNTRY 15

DOGS 15

TABLE 6 DOG (CANINE) POPULATION BY COUNTRY, 2010

(THOUSANDS) 16

FIGURE 1 DOG (CANINE) POPULATION—TOP 10 COUNTRIES, 2010

(THOUSANDS) 17

CATS 17

TABLE 7 CAT (FELINE) POPULATION BY COUNTRY (THOUSANDS) 18

FIGURE 2 CAT (FELINE) POPULATION—TOP 10 COUNTRIES, 2010

(THOUSANDS) 19

HORSES 19

TABLE 8 HORSE (EQUINE) POPULATION BY COUNTRY

(THOUSANDS) 20

TABLE 8 (CONTINUED) 21

FIGURE 3 HORSE (EQUINE) POPULATION—TOP 10 COUNTRIES,

2010 (THOUSANDS) 21

FIGURE 3 (CONTINUED) 22

CATTLE 22

TABLE 9 CATTLE (BOVINE) POPULATION BY COUNTRY

(THOUSANDS) 22

TABLE 9 (CONTINUED) 23

FIGURE 4 CATTLE (BOVINE) POPULATION—TOP 10 COUNTRIES,

2010 (THOUSANDS) 24

SWINE 24

TABLE 10 PIG/HOG (SWINE) POPULATION BY COUNTRY

(THOUSANDS) 25

FIGURE 5 PIG/HOG (SWINE) POPULATION—TOP 10 COUNTRIES,

2010 (THOUSANDS) 26

SHEEP/LAMB 26

TABLE 11 SHEEP/LAMB POPULATION BY COUNTRY

(THOUSANDS) 27

FIGURE 6 SHEEP/LAMB POPULATION—TOP 10 COUNTRIES, 2010

(THOUSANDS) 28

GOATS 28

TABLE 12 GOAT POPULATION BY COUNTRY (THOUSANDS) 29

FIGURE 7 GOAT POPULATION—TOP 10 COUNTRIES, 2010

(THOUSANDS) 30

TABLE 13 COUNTRIES WITH THE HIGHEST REPORTED ANIMAL

POPULATIONS (MILLIONS) 31

COMPANION ANIMAL DISEASES 32

INFECTIOUS DISEASES 32

Viruses 32

Adenovirus 32

Avian Influenza 33

Coronavirus 33

Distemper 34

Eastern Equine Encephalitis 34

Equine Viral Arteritis 35

Feline Calicivirus and Feline Herpes Virus 35

Feline Immunosuppressive Virus 35

Feline Infectious Peritonitis Virus 36

Feline Leukemia Virus 36

Infectious Hepatitis 37

Internal Papillomatosis of Parrots 37

Newcastle Disease 37

Pacheco's Disease 38

Parainfluenza Virus 39

Paramyxoviruses 39

Parvovirus 40

Polyomavirus 40

Poxviruses 40

Psittacine Beak and Feather Disease 41

Rabies 41

Reovirus 42

West Nile Virus 42

Bacteria 43

Black Tongue 43

Bordetella 43

Brucellosis 43

Campylobacteriosis 44

Chlamydia 44

Leptospirosis 45

Lyme Disease 45

Q Fever 46

Respiratory Mycoplasmosis 46

Spirochaetaceae 47

Tetanus 47

Allergy and Inflammatory Diseases 47

Allergies 47

Arthritis 48

Asthma 48

Dermatitis 49

Eosinophilic Granuloma Complex 49

Gout 49

Inflammatory Bowel Disease 50

Metabolic Diseases 51

Cushing's Syndrome 51

Diabetes Mellitus 51

Thyroid Disease 52

Pancreatitis 53

Metabolic Bone Disease in Birds 53

Parasitic Diseases 54

Ear Mites 54

Fleas 54

Fleas (Continued) 55

Heartworm 56

Hemobartonellosis 57

Feline Scabies 57

Lice 57

Sarcoptic Mange 58

Worms 58

Urinary Diseases 59

Glomerulonephritis 59

Feline Lower Urinary Tract Disease 59

Other Diseases 60

Equine Protozoal Myelitis 60

Leptospirosis and Equine Recurrent Uveitis 61

Neoplastic Disease 61

Neoplastic … (Continued) 62

Heart Disease 63

FOOD ANIMAL DISEASES 63

INFECTIOUS DISEASES 63

Viruses and Prions 63

Avian Pneumovirus 64

Bovine Spongiform Encephalopathy 64

Bovine Viral Diarrhea 65

Classical Swine Fever 66

Foot and Mouth Disease 67

Furunculosis 67

Infectious Pancreatic Necrosis 67

Marek's Disease 68

Pathogenic Avian Influenza 68

Q Fever 68

Vesicular Stomatitis 69

Bacteria 69

Anthrax 69

Blackleg 70

Conjunctivitis 70

Tetanus 70

OTHER DISEASES OF FOOD ANIMALS 71

Heartwater 71

Pneumonia 71

Texas Cattle Fever 72

ZOONOTIC DISEASES 72

ZOONOTIC DISEASES (CONTINUED) 73

ZOONOTIC DISEASES (CONTINUED) 74

TABLE 14 COMMON EXAMPLES OF ZOONOTIC DISEASES 75

CHAPTER FOUR: ISSUES AFFECTING THE MARKET 76

ANTIBIOTIC USE AND RESISTANCE IN FOOD ANIMALS 76

THERAPEUTIC USE 76

TABLE 15 CURRENT LIST OF APPROVED

ANTIBIOTICS/ANTIMICROBIALS USED IN FOOD-PRODUCING

ANIMALS IN THE UNITED STATES 77

TABLE 15 (CONTINUED) 78

Resistance 78

TABLE 16 ANTIMICROBIAL DRUG USE AND SALES IN FOODPRODUCING

ANIMALS, 2010 79

TABLE 16 (CONTINUED) 80

Human Side-Effects 80

Microbial Ecology 81

Agriculture and Food Research Initiative 81

Levels of Contaminated Meats in the U S 82

PROBIOTICS 82

LEGAL AND REGULATORY ISSUES 82

MINIMALLY AND HIGHLY REGULATED PRODUCTS 82

ANIMAL DRUG USER FEE ACT OF 2003 83

ANIMAL DRUG USER FEE AMENDMENTS OF 2008 (ADUFA

II) 83

ADVANCES IN DRUG DELIVERY 83

TRANSDERMAL (SPRAY-ON) DRUGS 83

SUBLINGUAL (UNDER THE TONGUE) DRUGS 84

BIOTECHNOLOGY IN ANIMAL HEALTH 84

ANIMAL CLONING 85

TRENDS IN COMPANION PET OWNERSHIP 85

TRENDS IN COMPANION … (CONTINUED) 86

ANIMAL HEALTH INSURANCE 87

TABLE 17 APPA NATIONAL PET OWNERS SURVEY, 2011-2012 BASIC

ANNUAL EXPENSES FOR DOGS AND CATS ($) 88

TABLE 18 DOG INSURANCE PLAN COMPARISONS, UNITED

STATES ($) 88

TABLE 18 (CONTINUED) 89

TABLE 19 CAT INSURANCE PLAN COMPARISONS, UNITED STATES

($) 89

ANIMAL OBESITY 90

CAUSES 90

WEIGHT REDUCTION 91

DEMAND IN THE VETERINARY SERVICE INDUSTRY 92

TABLE 20 ESTIMATED NUMBER OF VETERINARIAN PRACTICES IN

THE UNITED STATES BY TYPE OF PRACTICE, 2011 (NUMBER/%) 93

TABLE 21 ESTIMATED NUMBER OF VETERINARIAN'S IN THE

UNITED STATES BY YEAR, 2007–2011 93

FIGURE 8 ESTIMATED NUMBER OF VETERINARIAN'S IN THE

UNITED STATES BY YEAR, 2007-2011 94

ADVANCED MEDICAL PROCEDURES 94

ADVANCED MEDICAL PROCEDURES (CONTINUED) 95

ADVANCED MEDICAL PROCEDURES (CONTINUED) 95

LIFE CYCLE APPROACH 96

INTERNATIONAL ISSUES AND TRENDS 97

TABLE 22 ESTIMATED POPULATIONS OF COMPANION ANIMALS

IN JAPAN AND AUSTRALIA, 2010 (MILLIONS) 98

TABLE 23 ESTIMATED POPULATIONS OF FARM ANIMALS IN

ARGENTINA, BRAZIL AND INDIA, 2010 (MILLIONS) 99

CHAPTER FIVE: ANIMAL VACCINES 100

OVERVIEW 100

PRODUCT DESCRIPTION 100

ACTIVE IMMUNITY 100

PASSIVE IMMUNITY 101

OTHER TYPES 101

TARGET SPECIES AND PROVIDERS 102

TABLE 24 VACCINES BY TARGET SPECIES AND PROVIDERS 102

TABLE 24 (CONTINUED) 103

TABLE 24 (CONTINUED) 104

TABLE 24 (CONTINUED) 105

TABLE 24 (CONTINUED) 106

COMPANION ANIMAL VACCINES 106

BOEHRINGER INGELHEIM/VETMEDICA 106

HESKA 106

MERCK 106

MERIAL 107

NOVARTIS 108

PFIZER 108

FOOD ANIMAL VACCINES 108

BAYER 108

BOEHRINGER INGELHEIM 108

MERCK & COMPANY 109

MERIAL 110

NOVARTIS 110

PFIZER 110

MARKET ANALYSIS AND CONCLUSIONS 111

MARKETS BY USE OR APPLICATION 111

TABLE 25 MARKET ANALYSIS FOR ANIMAL VACCINES BY USE,

THROUGH 2016 ($ MILLIONS) 111

FIGURE 9 MARKET ANALYSIS FOR ANIMAL VACCINES BY USE,

2008-2016 ($ MILLIONS) 112

VACCINE MARKET BY TYPE 112

TABLE 26 ESTIMATED REVENUES FOR ANIMAL VACCINES BY

TYPE, THROUGH 2016 ($ MILLIONS) 113

FIGURE 10 ESTIMATED REVENUES FOR ANIMAL VACCINES BY

TYPE, 2008-2016 ($ MILLIONS) 114

MARKETS BY GEOGRAPHICAL REGION 114

TABLE 27 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES

BY WORLD REGION, 2011 (%/$ MILLIONS) 115

FIGURE 11 DISTRIBUTION OF REVENUES FOR ANIMAL VACCINES

BY WORLD REGION, 2011 (%) 115

COMPETITIVE SUMMARY 116

TABLE 28 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY

COMPETITOR REVENUE, 2011 (%/$ MILLIONS) 116

FIGURE 12 COMPETITIVE SUMMARY FOR ANIMAL VACCINES BY

COMPETITOR REVENUE, 2011 ($ MILLIONS) 117

CHAPTER SIX: ANIMAL PHARMACEUTICAL PRODUCTS 118

OVERVIEW 118

PRODUCT DESCRIPTION 118

ALLERGY AND RESPIRATORY DRUGS 118

TARGET SPECIES AND PROVIDERS 119

TABLE 29 ALLERGY AND RESPIRATORY DRUGS BY TARGET

SPECIES AND PROVIDERS 119

ANTI-INFECTIVES AND ANTIFUNGALS 119

Bayer 120

Boehringer Ingelheim 120

ECO 120

Elanco 120

Esteve 121

Merck Animal Health 121

Novartis 122

Pfizer 122

Virbac 123

Target Species and Providers 123

TABLE 30 ANTI-INFECTIVES BY TARGET SPECIES AND

PROVIDERS 123

TABLE 30 (CONTINUED) 124

TABLE 30 (CONTINUED) 125

ANTI-INFLAMMATORIES AND ANALGESICS 125

Bayer 125

Boehringer Ingelheim 125

Esteve 125

Merck Animal Health 126

Novartis 126

Pfizer 126

Target Species and Providers 127

TABLE 31 ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET

SPECIES AND PROVIDERS 127

METABOLIC DRUGS 127

Target Species and Providers 128

TABLE 32 METABOLIC DRUGS BY TARGET SPECIES AND

PROVIDERS 128

PARASITICIDES 128

Bayer 129

ECO 129

Elanco 129

Merck Animal Health 130

Merial 131

Novartis 132

Novartis (Continued) 133

Pfizer 134

Virbac 134

Target Species and Providers 134

TABLE 33 PARASITICIDES BY TARGET SPECIES AND PROVIDERS 134

TABLE 33 (CONTINUED) 135

TABLE 33 (CONTINUED) 136

OTHER PHARMACEUTICALS 136

OPK Biotech 136

Elanco 136

Esteve 137

Merck Animal Health 137

Merial 137

Novartis 138

Virbac 138

Dental 138

Target Species and Providers 138

TABLE 34 OTHER PHARMACEUTICALS BY TARGET SPECIES AND

PROVIDERS 138

TABLE 34 (CONTINUED) 139

MARKET ANALYSIS AND CONCLUSIONS 139

MARKETS BY USE OR APPLICATION 139

Allergy and Respiratory Market 139

TABLE 35 MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY

PRODUCTS BY USE, THROUGH 2016 ($ MILLIONS) 140

FIGURE 13 MARKET ANALYSIS FOR ALLERGY AND RESPIRATORY

PRODUCTS BY USE, 2008-2016 ($ MILLIONS) 140

Anti-Infective Market 141

TABLE 36 MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE,

THROUGH 2016 ($ MILLIONS) 141

FIGURE 14 MARKET ANALYSIS FOR ANTI-INFECTIVES BY USE,

2008-2016 ($ MILLIONS) 142

Anti-Inflammatory Market 142

TABLE 37 MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND

ANALGESICS BY USE, THROUGH 2016 ($ MILLIONS) 143

FIGURE 15 MARKET ANALYSIS FOR ANTI-INFLAMMATORIES AND

ANALGESICS BY USE, 2008-2016 ($ MILLIONS) 143

Metabolic Drug Market 143

TABLE 38 MARKET ANALYSIS FOR METABOLIC DRUGS BY USE,

THROUGH 2016 ($ MILLIONS) 144

FIGURE 16 MARKET ANALYSIS FOR METABOLIC DRUGS BY USE,

2008-2016 ($ MILLIONS) 144

Parasiticide Market 145

TABLE 39 MARKET ANALYSIS FOR PARASITICIDES BY USE,

THROUGH 2016 ($ MILLIONS) 145

FIGURE 17 MARKET ANALYSIS FOR PARASITICIDES BY USE, 2008-

2016 ($ MILLIONS) 146

Other Pharmaceuticals 146

TABLE 40 MARKET ANALYSIS FOR OTHER PHARMACEUTICALS BY

USE, THROUGH 2016 ($ MILLIONS) 147

FIGURE 18 MARKET ANALYSIS FOR OTHER PHARMACEUTICALS

BY USE, 2008-2016 ($ MILLIONS) 147

TOTAL PHARMACEUTICALS 147

TABLE 41 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL

PRODUCTS BY USE, THROUGH 2016 ($ MILLIONS) 148

FIGURE 19 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL

PRODUCTS BY USE, 2008-2016 ($ MILLIONS) 148

SUMMARY—PHARMACEUTICAL MARKETS 149

TABLE 42 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL

PRODUCTS BY TYPE, THROUGH 2016 ($ MILLIONS) 150

FIGURE 20 MARKET ANALYSIS FOR ANIMAL PHARMACEUTICAL

PRODUCTS BY TYPE, 2008-2016 ($ MILLIONS) 150

MARKETS BY GEOGRAPHICAL REGION 151

TABLE 43 DISTRIBUTION OF REVENUES FOR ANIMAL

PHARMACEUTICALS BY WORLD REGION, 2011 (%) 151

FIGURE 21 DISTRIBUTION OF REVENUES FOR ANIMAL

PHARMACEUTICALS BY WORLD REGION, 2011 (%) 152

COMPETITIVE SUMMARY 152

TABLE 44 COMPETITIVE SUMMARY FOR ANIMAL

PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES,

2011 ($ MILLIONS) 153

FIGURE 22 COMPETITIVE SUMMARY FOR ANIMAL

PHARMACEUTICAL PRODUCTS BY COMPETITOR REVENUES,

2011 ($ MILLIONS) 153

CHAPTER SEVEN: ANIMAL FEED ADDITIVES 154

OVERVIEW 154

PRODUCT DESCRIPTION 155

AMINO ACIDS 155

ADISSEO 155

AJINOMOTO 155

EVONIK 156

NOVUS INTERNATIONAL 156

TARGET SPECIES AND PROVIDERS 156

TABLE 45 AMINO ACIDS BY TARGET SPECIES AND PROVIDERS 156

MEDICINAL ADDITIVES 157

ELANCO 157

MERIAL 157

NOVARTIS 157

PFIZER 158

TARGET SPECIES AND PROVIDERS 159

TABLE 46 MEDICINAL ADDITIVES BY TARGET SPECIES AND

PROVIDERS 159

NUTRITIONAL SUPPLEMENTS 160

ADISSEO 160

BASF 160

BOEHRINGER INGELHEIM 160

DSM NUTRITIONAL PRODUCTS 160

ESTEVE 161

HESKA 161

MOSAIC 161

VETERINARY PRODUCTS LABORATORIES 161

VIRBAC 161

TARGET SPECIES AND PROVIDERS 162

TABLE 47 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES

AND PROVIDERS 162

VITAMINS AND MINERALS 162

ADISSEO 163

BEAPHAR 163

CHURCH & DWIGHT CO 163

DSM NUTRITIONAL 163

MERCK ANIMAL HEALTH 163

PFIZER 164

TARGET SPECIES AND PROVIDERS 164

TABLE 48 VITAMINS AND MINERALS BY TARGET SPECIES AND

PROVIDERS 164

MARKET ANALYSIS AND CONCLUSION 165

MARKETS BY USE OR APPLICATION 165

Amino Acid Market 165

TABLE 49 MARKET ANALYSIS FOR AMINO ACIDS BY USE,

THROUGH 2016 ($ MILLIONS) 165

FIGURE 23 MARKET ANALYSIS FOR AMINO ACIDS BY USE, 2008-

2016 ($ MILLIONS) 166

Medicinal Feed Additive Market 166

TABLE 50 MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES

BY USE, THROUGH 2016 ($ MILLIONS) 167

FIGURE 24 MARKET ANALYSIS FOR MEDICINAL FEED ADDITIVES

BY USE, 2008-2016 ($ MILLIONS) 167

Nutritional Supplement Market 167

TABLE 51 MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS

BY USE, THROUGH 2016 ($ MILLIONS) 168

FIGURE 25 MARKET ANALYSIS FOR NUTRITIONAL SUPPLEMENTS

BY USE, 2008-2016 ($ MILLIONS) 169

Vitamin and Mineral Market 169

TABLE 52 MARKET ANALYSIS FOR VITAMINS AND MINERALS BY

USE, THROUGH 2016 ($ MILLIONS) 170

FIGURE 26 MARKET ANALYSIS FOR VITAMINS AND MINERALS BY

USE, 2008-2016 ($ MILLIONS) 170

Total Feed Additive Market 170

TABLE 53 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY

USE, THROUGH 2016 ($ MILLIONS) 171

FIGURE 27 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVES BY

USE, 2008-2016 ($ MILLIONS) 171

FEED ADDITIVE MARKET BY TYPE 172

TABLE 54 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE

PRODUCTS BY TYPE, THROUGH 2016 ($ MILLIONS) 173

FIGURE 28 MARKET ANALYSIS FOR ANIMAL FEED ADDITIVE

PRODUCTS BY TYPE, 2008-2016 ($ MILLIONS) 173

MARKETS BY GEOGRAPHICAL REGION 174

TABLE 55 DISTRIBUTION OF REVENUES FOR ANIMAL FEED

ADDITIVES BY WORLD REGION, 2011 (%) 174

FIGURE 29 DISTRIBUTION OF REVENUES FOR ANIMAL FEED

ADDITIVES BY WORLD REGION, 2011 (%) 175

COMPETITIVE SUMMARY 175

TABLE 56 COMPETITIVE SUMMARY FOR ANIMAL FEED

ADDITIVES BY COMPETITOR REVENUES, 2011 (%/$ MILLIONS) 176

FIGURE 30 COMPETITIVE SUMMARY FOR ANIMAL FEED

ADDITIVES BY COMPETITOR REVENUES, 2011 ($ MILLIONS) 177

CHAPTER EIGHT: ANIMAL DIAGNOSTICS 178

OVERVIEW 178

PRODUCT DESCRIPTION 178

HESKA 178

IDEXX 179

IDEXX (Continued) 180

IDEXX (Continued) 181

MERCK ANIMAL HEALTH 182

SYNBIOTICS 182

TARGET SPECIES AND PROVIDERS 183

TABLE 57 DIAGNOSTICS BY TARGET SPECIES AND PROVIDERS 183

TABLE 57 (CONTINUED) 184

TABLE 57 (CONTINUED) 185

MARKET ANALYSIS AND CONCLUSION 186

MARKETS BY USE OR APPLICATION 186

TABLE 58 MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS

PRODUCTS BY USE, THROUGH 2016 ($ MILLIONS) 186

FIGURE 31 MARKET ANALYSIS FOR ANIMAL DIAGNOSTICS

PRODUCTS BY USE, 2008-2016 ($ MILLIONS) 187

DIAGNOSTIC MARKET BY TYPE 187

TABLE 59 REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE,

THROUGH 2016 ($ MILLIONS) 188

FIGURE 32 REVENUES FOR ANIMAL DIAGNOSTICS BY TYPE, 2008-

2016 ($ MILLIONS) 188

Diagnostic Rapid Testing 188

TABLE 60 REVENUES FOR RAPID DIAGNOSTICS BY TYPE

(VETERINARY APPLICATIONS), THROUGH 2016 ($ MILLIONS) 189

FIGURE 33 REVENUES FOR RAPID DIAGNOSTICS BY TYPE

(VETERINARY APPLICATIONS), 2008-2016 ($ MILLIONS) 190

Diagnostic Analyzers and Consumables 190

TABLE 61 REVENUES FOR DIAGNOSTIC ANALYZERS AND

CONSUMABLES BY TYPE (VETERINARY APPLICATIONS),

THROUGH 2016 ($ MILLIONS) 191

FIGURE 34 REVENUES FOR DIAGNOSTIC ANALYZERS AND

CONSUMABLES BY TYPE (VETERINARY APPLICATIONS), 2008-

2016 ($ MILLIONS) 191

Diagnostic Imaging Equipment 191

MARKETS BY GEOGRAPHICAL REGION 192

TABLE 62 DISTRIBUTION OF REVENUES FOR ANIMAL

DIAGNOSTICS BY WORLD REGION, 2011 (%/$ MILLIONS) 192

FIGURE 35 DISTRIBUTION OF REVENUES FOR ANIMAL

DIAGNOSTICS BY WORLD REGION, 2011 (%) 193

COMPETITIVE SUMMARY 193

TABLE 63 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS

BY COMPETITOR REVENUES, 2011 ($ MILLIONS) 194

FIGURE 36 COMPETITIVE SUMMARY FOR ANIMAL DIAGNOSTICS

BY COMPETITOR REVENUES, 2011 ($ MILLIONS) 194

CHAPTER NINE: MARKET SUMMARY 195

TOTAL ANIMAL THERAPEUTICS AND DIAGNOSTIC MARKET

ANALYSIS 195

TABLE 64 TOTAL MARKET ANALYSIS FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT,

THROUGH 2016 ($ MILLIONS) 195

FIGURE 37 TOTAL MARKET ANALYSIS FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT,

2008-2016 ($ MILLIONS) 196

MARKETS BY USE OR APPLICATION 196

TABLE 65 TOTAL MARKET ANALYSIS FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE,

THROUGH 2016 ($ MILLIONS) 197

FIGURE 38 TOTAL MARKET ANALYSIS FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY ANIMAL TYPE, 2008-2016

($ MILLIONS) 198

MARKETS BY WORLD REGION 198

TABLE 66 DISTRIBUTION OF REVENUES FOR ANIMAL

THERPEUTICS AND DIAGNOSTICS BY WORLD REGION, 2011

(%/$ MILLIONS) 199

FIGURE 39 DISTRIBUTION OF REVENUES FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY WORLD REGION, 2011

(%) 200

INDUSTRY PARTICIPANTS BY TYPE 200

TABLE 67 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT TYPE 201

TOTAL COMPETITIVE ANALYSIS 201

Total Competitive Analysis (Continued) 202

TABLE 68 TOTAL COMPETITIVE MARKET SHARE FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER

REVENUES, 2011 ($ MILLIONS) 203

FIGURE 40 TOTAL COMPETITIVE SUMMARY FOR ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY COMPETITOR

REVENUES, 2011 ($ MILLIONS) 204

TABLE 69 COMPETITOR MARKET POSITION—ANIMAL

THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER

REVENUES, 2011 204

TABLE 69 (CONTINUED) 205

COMPANY ACQUISITIONS AND STRATEGIES 205

CHAPTER TEN: COMPANY PROFILES 206

ABAXIS INC 206

AUV VETERINARY COOPERATIVE 207

BASF ANIMAL NUTRITION (BASF SE) 208

BAYER ANIMAL HEALTH 208

BOEHRINGER INGELHEIM CORP 209

BOEHRINGER INGELHEIM GMBH 209

BOEHRINGER INGELHEIM VETMEDICA, INC 209

DSM NUTRITIONAL PRODUCTS LTD 210

ROYAL DSM N V 210

ELANCO ANIMAL HEALTH 210

EVONIK INDUSTRIES AG 211

HESKA CORP 212

IDEXX LABORATORIES INC 212

MERCK & CO INC 213

MOSAIC CO (THE) 214

NOVARTIS ANIMAL HEALTH INC 214

NOVARTIS AG 215

NOVUS INTERNATIONAL INC 215

PFIZER ANIMAL HEALTH 216

SANOFI 217

VIRBAC SA 218

APPENDICES 219

APPENDIX I: LEADING MANUFACTURES AND AFFILIATED

COMPANIES 219

ABAXIS INC 219

ACRUX LTD 219

ADISSEO FRANCE S A S 219

ADISSEO HONG KONG 219

AJINOMOTO CO LTD 220

AUV VETERINARY COOPERATIVE 220

BASF ANIMAL NUTRITION (BASF SE) 220

BAYER AG 220

BEAPHAR B V 220

BEN VENUE LABORATORIES INC 220

BOEHRINGER INGELHEIM CORP 221

BOEHRINGER INGELHEIM GMBH 221

BOEHRINGER INGELHEIM VETMEDICA INC 221

DSM NUTRITIONAL PRODUCTS LTD 221

ECO ANIMAL HEALTH 221

ELANCO ANIMAL HEALTH 221

ELI LILLY & CO 221

ESTEVE 222

ESTEVE USA INC 222

EUROVET 222

EVONIK INDUSTRIES AG 222

HESKA CORP 222

HUVEPHARMA AD 222

IDEXX LABORATORIES INC 223

LUITPOLD ANIMAL HEALTH 223

MERCK & CO INC 223

MERIAL ANIMAL HEALTH, LTD 223

MOSAIC CO (THE) 223

NOVARTIS AG 223

NOVARTIS ANIMAL HEALTH INC 224

NOVUS INTERNATIONAL INC 224

OPK BIOTECH LLC 224

PFIZER ANIMAL HEALTH 224

PHIBRO ANIMAL HEALTH CORPORATION 224

ROYAL DSM N V 224

SANOFI 225

SYNBIOTICS CORP 225

VIRBAC SA 225

APPENDIX II: RELEVANT ASSOCIATIONS AND ORGANIZATIONS 225

AMERICAN ASSOCIATION OF FELINE PRACTITIONERS 225

AMERICAN ASSOCIATION OF SWINE VETERINARIANS 225

AMERICAN HUMANE ASSOCIATION 225

AMERICAN PET PRODUCTS ASSOCIATION INC 225

AMERICAN SOCIETY FOR THE PREVENTION OF CRUELTY

TO ANIMALS 226

AMERICAN VETERINARY DISTRIBUTORS ASSOCIATION

(AVDA) 226

AMERICAN VETERINARY MEDICAL ASSOCIATION 226

CANADIAN VETERINARY MEDICAL ASSOCIATION 226

HUMANE SOCIETY OF THE UNITED STATES 226

NATIONAL ANIMAL CONTROL ASSOCIATION 226

PET FOOD INSTITUTE 227

SOCIETY OF ANIMAL WELFARE ADMINISTRATORS 227

UNITED STATES DEPARTMENT OF AGRICULTURE 227

UNITED STATES FOOD AND DRUG ADMINISTRATION 227

U S POULTRY AND EGG ASSOCIATION 227

To order this report:Veterinary healthcare Industry: Global Markets for Animal Therapeutics and Diagnostics

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... number of ,world firsts,: , TwinLink™ - ...
(Date:6/23/2016)... June 23, 2016 The vast majority of ... dialysis facility.  Treatments are usually 3 times a week, ... visit, including travel time, equipment preparation and wait time. ... especially grueling for patients who are elderly and frail.  ... nursing and rehabilitation centers for some duration of time. ...
(Date:6/23/2016)... Tenn. , June 23, 2016 /PRNewswire/ ... automating, integrating and transforming the patient payment ... of several innovative new products and services ... of its revenue cycle offerings. These award-winning ... more efficient workflows, remain compliant in an ...
Breaking Medicine Technology:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):